🇺🇸 FDA
Patent

US 7208154

Methods and compositions for the treatment of MHC-associated conditions

granted A61KA61K38/08A61K38/10

Quick answer

US patent 7208154 (Methods and compositions for the treatment of MHC-associated conditions) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/08, A61K38/10